Q3 2024 |
19 |
$2.31B |
+$122M |
-$507M |
-$385M |
DT, CYBR, TYL, GWRE, NICE
|
13F-HR |
11/13/2024, 04:41 PM |
Q2 2024 |
20 |
$2.5B |
+$130M |
-$22.5M |
+$108M |
CYBR, GWRE, TYL, NICE, DT
|
13F-HR |
8/13/2024, 04:44 PM |
Q1 2024 |
19 |
$2.48B |
+$54.9M |
-$194M |
-$139M |
NICE, CYBR, GWRE, TYL, DT
|
13F-HR |
5/14/2024, 12:44 PM |
Q4 2023 |
19 |
$2.44B |
+$159M |
-$246M |
-$86.5M |
CYBR, GWRE, NICE, DT, TENB
|
13F-HR |
2/13/2024, 02:05 PM |
Q3 2023 |
19 |
$2.19B |
+$128M |
-$109M |
+$19.6M |
CYBR, GWRE, TENB, DT, NICE
|
13F-HR |
11/13/2023, 04:53 PM |
Q2 2023 |
18 |
$2.24B |
+$125M |
-$91.7M |
+$33.3M |
CYBR, TENB, MANH, NOW, DT
|
13F-HR |
8/11/2023, 04:10 PM |
Q1 2023 |
18 |
$2.1B |
+$156M |
-$11.2M |
+$145M |
NICE, CYBR, TENB, TYL, MANH
|
13F-HR |
5/12/2023, 02:45 PM |
Q4 2022 |
18 |
$1.72B |
+$208M |
-$81M |
+$127M |
CYBR, NICE, TENB, TYL, BOX
|
13F-HR |
2/13/2023, 04:37 PM |
Q3 2022 |
17 |
$1.55B |
+$23.1M |
-$299M |
-$276M |
CYBR, NICE, MANH, TYL, TENB
|
13F-HR |
11/14/2022, 12:34 PM |
Q2 2022 |
18 |
$1.91B |
+$191M |
-$199M |
-$8.24M |
NICE, CYBR, BOX, NOW, VRNT
|
13F-HR |
8/12/2022, 04:14 PM |
Q1 2022 |
19 |
$2.41B |
+$390M |
-$257M |
+$133M |
CYBR, NICE, TENB, ZEN, VRNT
|
13F-HR |
5/13/2022, 10:34 AM |
Q4 2021 |
21 |
$2.4B |
+$405M |
-$153M |
+$252M |
NICE, CYBR, TENB, VRNT, NOW
|
13F-HR |
2/11/2022, 03:26 PM |
Q3 2021 |
18 |
$2.04B |
+$144M |
-$295M |
-$151M |
NICE, CYBR, TENB, VRNT, RAMP
|
Restatement |
11/15/2021, 04:23 PM |
Q2 2021 |
20 |
$2.16B |
+$349M |
-$591M |
-$243M |
NICE, CSOD, CYBR, NOW, TENB
|
13F-HR |
8/13/2021, 11:16 AM |
Q1 2021 |
23 |
$2.29B |
+$336M |
-$173M |
+$163M |
PFPT, NICE, BOX, NUAN, CSOD
|
13F-HR |
5/14/2021, 02:18 PM |
Q4 2020 |
22 |
$2.29B |
+$174M |
-$174M |
+$889K |
PFPT, NICE, NUAN, VRNT, RP
|
13F-HR |
2/16/2021, 10:53 AM |
Q3 2020 |
23 |
$1.78B |
+$253M |
-$275M |
-$21.4M |
NUAN, NICE, PFPT, BOX, VRNT
|
13F-HR |
11/16/2020, 11:39 AM |
Q2 2020 |
21 |
$1.66B |
+$134M |
-$172M |
-$38.2M |
NUAN, NICE, PFPT, BOX, VRNT
|
13F-HR |
8/14/2020, 11:03 AM |
Q1 2020 |
21 |
$1.27B |
+$128M |
-$285M |
-$157M |
NICE, NUAN, LMNX, BOX, RAMP
|
13F-HR |
5/14/2020, 04:08 PM |
Q4 2019 |
21 |
$1.75B |
+$135M |
-$62.9M |
+$71.8M |
TYL, VRNT, NICE, NUAN, LRCX
|
13F-HR |
2/14/2020, 01:26 PM |
Q3 2019 |
20 |
$1.5B |
+$210M |
-$144M |
+$66.3M |
TYL, NICE, LRCX, CSOD, NUAN
|
13F-HR |
11/14/2019, 04:47 PM |
Q2 2019 |
19 |
$1.39B |
+$100M |
-$120M |
-$19.9M |
MANH, VRNT, CSOD, TYL, NUAN
|
13F-HR |
8/14/2019, 09:56 AM |
Q1 2019 |
19 |
$1.47B |
+$170M |
-$215M |
-$44.4M |
VRNT, LRCX, MANH, NOW, CSOD
|
13F-HR |
5/15/2019, 11:20 AM |
Q4 2018 |
20 |
$1.19B |
+$306M |
-$169M |
+$136M |
CSOD, VRNT, LRCX, MANH, TYL
|
13F-HR |
2/14/2019, 03:15 PM |
Q3 2018 |
20 |
$1.26B |
+$146M |
-$108M |
+$37.9M |
VRNT, CSOD, MANH, IMPV, LRCX
|
13F-HR |
11/14/2018, 01:43 PM |
Q2 2018 |
21 |
$1.11B |
+$101M |
-$252M |
-$151M |
VRNT, CSOD, IMPV, MANH, SCOR
|
13F-HR |
8/13/2018, 04:50 PM |
Q1 2018 |
19 |
$1.14B |
+$167M |
-$133M |
+$34M |
CSOD, VRNT, LRCX, ACXM, TYL
|
13F-HR |
5/14/2018, 04:49 PM |
Q4 2017 |
18 |
$1.08B |
+$139M |
-$69.7M |
+$69.5M |
ACXM, CSOD, TYPE, VRNT, LRCX
|
13F-HR |
2/13/2018, 05:52 PM |
Q3 2017 |
17 |
$968M |
+$61M |
-$122M |
-$61M |
CSOD, ACXM, LRCX, SCOR, TYPE
|
13F-HR |
11/14/2017, 10:12 AM |
Q2 2017 |
21 |
$984M |
+$69.1M |
-$86M |
-$16.8M |
CSOD, ACXM, SCOR, VRNT, LRCX
|
13F-HR |
8/14/2017, 03:44 PM |
Q1 2017 |
22 |
$957M |
+$96.6M |
-$94.3M |
+$2.31M |
ACXM, VRNT, LRCX, CSOD, ENTG
|
13F-HR |
5/12/2017, 04:11 PM |
Q4 2016 |
21 |
$918M |
+$117M |
-$51.3M |
+$65.5M |
ACXM, LRCX, CSOD, ENTG, VRNT
|
13F-HR |
2/14/2017, 02:14 PM |
Q3 2016 |
21 |
$888M |
+$79.3M |
-$144M |
-$65.1M |
ACXM, LRCX, ENTG, CSOD, VRNT
|
13F-HR |
11/14/2016, 12:11 PM |
Q2 2016 |
21 |
$831M |
+$50.9M |
-$99.9M |
-$49M |
LRCX, ACXM, CSOD, ENTG, TYL
|
13F-HR |
8/15/2016, 11:34 AM |
Q1 2016 |
20 |
$796M |
+$99.6M |
-$21M |
+$78.6M |
LRCX, CSOD, AZPN, BLKB, ENTG
|
13F-HR |
5/13/2016, 04:29 PM |
Q4 2015 |
21 |
$765M |
+$70.4M |
-$102M |
-$31.2M |
LRCX, AZPN, BLKB, ENTG, SHOR
|
13F-HR |
2/16/2016, 01:43 PM |
Q3 2015 |
21 |
$749M |
+$144M |
-$20.8M |
+$123M |
LRCX, AZPN, BLKB, ENTG, CTCT
|
13F-HR |
11/16/2015, 09:26 AM |
Q2 2015 |
21 |
$708M |
+$119M |
-$79.8M |
+$39.6M |
LRCX, AZPN, BLKB, ANGO, ENTG
|
13F-HR |
8/13/2015, 04:42 PM |
Q1 2015 |
19 |
$603M |
+$63M |
-$87.9M |
-$24.9M |
AZPN, LRCX, BLKB, TYL, ANGO
|
13F-HR |
5/14/2015, 02:36 PM |
Q4 2014 |
19 |
$657M |
+$128M |
-$110M |
+$18M |
AZPN, TYL, LRCX, ANGO, BLKB
|
13F-HR |
2/13/2015, 09:55 AM |
Q3 2014 |
20 |
$574M |
+$56M |
-$23.4M |
+$32.7M |
AZPN, LRCX, KFX, TYL, ANGO
|
13F-HR |
11/13/2014, 09:53 AM |
Q2 2014 |
20 |
$600M |
+$146M |
-$102M |
+$43.3M |
AZPN, KFX, LRCX, TYL, ANGO
|
13F-HR |
8/18/2014, 04:02 PM |
Q1 2014 |
20 |
$546M |
+$93.9M |
-$99M |
-$5.13M |
ACCL, AZPN, LRCX, ANGO, KFX
|
13F-HR |
5/14/2014, 07:48 PM |
Q4 2013 |
19 |
$553M |
$0 |
$0 |
|
AZPN, ACCL, ANGO, LRCX, ATMI
|
Restatement |
2/12/2014, 04:27 PM |